Close

  We have detected that you are in USA. Don’t you want to visit    USA   www.tuugo.us?

TrakCel
     
  •  

    About Us

    TrakCel is the first provider of integrated cellular orchestration solutions for the precise management, control and tracking of cell and gene therapy products. With the largest number of live deployments supporting the broadest number of therapy classes in industry, TrakCel has built a deep understanding of the unique challenges faced by advanced therapy developers globally.

    Our goal is to provide cell and gene therapy software solutions that offer visibility, insight and scalability to streamline the delivery of therapies to patients at their most vulnerable.

         |   Our company in social networks

 
11 Raleigh Walk, Waterfront 2000, CF10 4LN
Show on map
id0300004300411
Other search results for: TrakCel
REQUEST TO REMOVECell and Gene Therapy Orchestration Solutions | TrakCel
https://trakcel.com/

TrakCel solutions combine ease of use, patient journey and full audit trail without the need for paper records, offering a regulatory compliant solution for both Clinical Trial and Commercial settings. A complete, connected solution to cell and gene supply chain management challenges. Our Product and Professional Services are backed by industry experts with extensive … 

REQUEST TO REMOVECatalent Opens New Clinical Supply Facility In San Diego ...
https://www.contractpharma.com/contents/view_breaking-news/2021-10-28/catalent-opens-new-clinical-supply-facility-in-san-diego/

28/10/2021 · Catalent, a global leader in clinical supply services, has opened a new facility in San Diego, in response to increased demand from pharma and biopharma customers for integrated development, clinical packaging, and distribution services on the U.S. West Coast.The new facility marks the latest expansion to Catalent’s global clinical supply network, and follows the opening … 

REQUEST TO REMOVEPfizer-BioNTech Provide Update On COVID Vax And Omicron ...
https://www.contractpharma.com/contents/view_breaking-news/2021-12-08/pfizer-biontech-provide-update-on-covid-vax-and-omicron/

08/12/2021 · Pfizer Inc. and BioNTech’s results from an initial laboratory study demonstrate that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccines one month after receiving the booster vaccination neutralized the Omicron variant to levels that are comparable … 

REQUEST TO REMOVEPeople
https://trakcel.peoplehr.net/

Please enter your login details. Email. Next 

REQUEST TO REMOVEFlexible supply chain orchestration – TrakCel and BINOCS ...
https://www.pharmiweb.com/press-release/2021-12-09/flexible-supply-chain-orchestration-trakcel-and-binocs-announce-a-partnership-to-support-scalability-and-scheduling-requirements-for-cell-gene-the

09/12/2021 · About TrakCel. TrakCel is the leading innovator of integrated technologies specifically created in 2012 to manage the international autologous and allogeneic cell, gene and immunotherapy supply chain. TrakCel's software platform, OCELLOS, has been developed in collaboration with, and increasingly adopted by leading companies in the cell, gene ... 

REQUEST TO REMOVEBinocs And TrakCel Partner To Integrate Their Software As ...
https://www.contractpharma.com/contents/view_breaking-news/2021-12-08/binocs-and-trakcel-partner-to-integrate-their-software-as-a-service-solutions/

08/12/2021 · Meanwhile, TrakCel will implement OCELLOS to track and report client Chain of Identity (CoI) and Chain of Custody (CoC), critical measures for ensuring patient safety and in supporting the volatile CGT supply chain. Despite their exceptional therapeutic and curative nature, CGT products are prescribed at a very fragile point in a patient’s treatment. Ensuring … 

REQUEST TO REMOVEGS Verde Law | Raising investment Wales & South West ...
https://www.gsverde.law/

Dr. Matthew Lakelin, Chief Scientific Officer, TrakCel. We have been using Greenaway Scott as our legal counsel for over a year now, and have found them to be incredibly useful. They have helped us with our shareholder’s agreement over 2 investment rounds now, and with everything else – from employee contracts to our platform terms and conditions. They’re always on hand … 

REQUEST TO REMOVEDriving the next wave of innovation in CAR T-cell ...
https://www.mckinsey.com/industries/life-sciences/our-insights/driving-the-next-wave-of-innovation-in-car-t-cell-therapies

13/12/2019 · Some have also partnered with software companies, such as Vineti and TrakCel, to offer digitized technology solutions that trace and track cell therapies with enhanced transparency. 6 Most critical to patient outcomes is the “vein to vein” time, often defined as the time that elapses between apheresis and product delivery at the hospital. Given the rapid progression of … 

REQUEST TO REMOVECAR-T Therapy Treatment Market 2021: Industry Growth ...
https://www.digitaljournal.com/pr/car-t-therapy-treatment-market2021-industry-growth-competitive-analysis-future-prospects-and-forecast-2028

09/12/2021 · CAR-T Therapy Treatment Market report systematically collects the information about influencing factors for the industry which includes customer behavior, emerging trends, product usage, and brand ... 

REQUEST TO REMOVECAR-T Therapy Treatment Market Status and Outlook 2021 ...
https://www.digitaljournal.com/pr/car-t-therapy-treatment-marketstatus-and-outlook-2021-2028-shared-in-a-latest-research-available-at-dbmr

10/12/2021 · CAR-T Therapy Treatment Market document, market segmentation is performed in terms of markets covered, geographic scope, years considered for the study, currency and pricing, research methodology ... 

REQUEST TO REMOVECPhI Annual Report Predicts the Pharma Environment in 2030
https://www.contractpharma.com/contents/view_breaking-news/2021-10-27/cphi-annual-report-predicts-the-pharma-environment-in-2030/

27/10/2021 · The second part of the 2021 CPhI Annual Report looks ahead to predict the pharma manufacturing, therapeutic and technology environment in 2030. The report foresees the use of automated cobots, AI, real-time release and rapid growth in new areas like mRNA vaccines, alongside the personalization of Therapeutics (delivered at far larger scale). In terms of … 

REQUEST TO REMOVEBioInsights - Webinars
https://insights.bio/cell-and-gene-therapy-insights/webinars/

Vice President, Corporate Development & Strategy at TrakCel Ltd . Jason Krentz. CTO at Tmunity Therapeutics Inc . 5 September 2019. Watch now. Accelerating advancement in gene therapy by improving downstream purification... O Terova H Brahmbhatt Orjana Terova. Senior Product Manager, POROS Chromatography Product Line at Thermo Fisher Scientific ... 

TrakCel11 Raleigh Walk, Waterfront 2000CF10 4LNCardiffCardiff - Wales02920 483 729 https://static.tuugo.co.uk/images/96/294/trakcel_.jpg https://static.tuugo.co.uk/images/53/469/trakcel_.jpg
 
We and third party providers from us use cookies on our pages. By continuing to browse our pages you agree to that and accept our Cookie Policy.